A Study of TAK-861 for the Treatment of Narcolepsy Type 1

Clinical trial NCT06470828 · COMPLETED

Trial details

NCT number: NCT06470828
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Narcolepsy Type 1

Start date: 2024-07-02
Primary completion: 2025-06-03
Enrollment: 168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.